FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Device, Hemostasis, Vascular
PMA: P040044
·
Supplement: S113
·
Decision May 14, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0
Research PMA P040044 in seconds
The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- Device, Hemostasis, Vascular
- Trade Name
- Cordis Mynx Vascular Closure Portfolio (VCP): MynxGrip, Mynx Control, and Mynx Control Venous Vascular Closure
- PMA Number
- P040044
- Supplement Number
- S113
- Device Class
- FDA Class 3
- Product Code
- MGB
- Generic Name
- Device, hemostasis, vascular
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- May 14, 2026
- Date Received
- April 14, 2026
- Supplement Type
- Special (Immediate Track)
- Supplement Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Expedited Review
- N
Advisory Committee Statement
the addition of a supplemental patient pamphlet as an optional accompaniment to the Mynx patient brochure
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MGB | Device, Hemostasis, Vascular | FDA class 3 | Unknown |